Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 25829144)

Published in Neuropsychopharmacology on April 01, 2015

Authors

Mohamed Ahmed1, Dara M Cannon1, Cathy Scanlon1, Laurena Holleran1, Heike Schmidt1, John McFarland1, Camilla Langan1, Peter McCarthy2, Gareth J Barker3, Brian Hallahan1, Colm McDonald1

Author Affiliations

1: Clinical Neuroimaging Laboratory, Department of Psychiatry, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Galway, Ireland.
2: Department of Radiology, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Galway, Ireland.
3: King's College London, Centre for Neuroimaging Sciences, Department of Neuroimaging, Institute of Psychiatry, London, UK.

Articles cited by this

The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07

Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry (1976) 15.48

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage (2008) 12.12

The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain (1999) 5.13

Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage (2012) 5.11

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91

Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med (2009) 3.34

The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry (2008) 3.29

Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr (2001) 2.67

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry (2003) 2.39

The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry (1998) 2.24

Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98

Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull (2012) 1.97

Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry (1998) 1.70

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68

Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophr Res (2010) 1.64

Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58

Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.46

Changes in caudate volume with neuroleptic treatment. Lancet (1994) 1.43

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev (2013) 1.40

Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res (2007) 1.39

Effects of antipsychotics on brain structure. Curr Opin Psychiatry (2006) 1.33

Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry (2006) 1.23

The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21

Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry (2011) 1.21

Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20

Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res (2005) 1.09

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry (2001) 1.06

A comparison of MR based segmentation methods for measuring brain atrophy progression. Neuroimage (2010) 1.05

Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry (2010) 1.05

Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology (2004) 0.99

The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage. Neurobiol Learn Mem (2005) 0.91

Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison. Schizophr Res (2013) 0.90

Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.89

Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia. Schizophr Res (2010) 0.89

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology (2001) 0.88

Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients. Psychiatry Res (2004) 0.88

Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res (2004) 0.85

Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review. Curr Med Chem (2013) 0.84

Gray matter volume decreases in elderly patients with schizophrenia: a voxel-based morphometry study. Schizophr Bull (2011) 0.81

Cortical signature of neurological soft signs in recent onset schizophrenia. Brain Topogr (2013) 0.79